Novel antibody specificities targeting glycoprotein B of cytomegalovirus identified by molecular library technology.

Abstract : Antibodies provide some protection against cytomegalovirus-mediated disease. All aspects of antibody recognition of important viral antigens are, however, not fully appreciated. Glycoprotein B (gB), a key protein in the viral membrane, participates in viral infection and it is a component of prototype vaccines. By using combinatorial antibody library and selection technology, novel antibody specificities targeting gB have now been isolated. We define a monoclonal antibody fragment able to recognize site I of antigenic domain (AD) 2, a poorly immunogenic epitope targeted by potent virus-neutralizing antibodies, in a way that is different from the binding of antibodies induced by infection but similar to those induced by vaccination. We also describe the existence of a novel epitope overlapping site I of AD-2 and AD-1, the immunodominant epitope of gB. These specificities, derived by molecular engineering, will be useful for the future assessment of humoral immune responses against this opportunistic viral infection.
Document type :
Journal articles
Complete list of metadatas

https://hal-riip.archives-ouvertes.fr/pasteur-00819966
Contributor : Charles M. Dozois <>
Submitted on : Thursday, May 2, 2013 - 9:14:36 PM
Last modification on : Friday, May 24, 2019 - 11:10:02 PM

Identifiers

Collections

Citation

Fredrika Axelsson, Jonas Persson, Emmanuel Moreau, Marie-Hélène Côté, Alain Lamarre, et al.. Novel antibody specificities targeting glycoprotein B of cytomegalovirus identified by molecular library technology.. New Biotechnology, Elsevier, 2009, 25 (6), pp.429-36. ⟨10.1016/j.nbt.2009.05.003⟩. ⟨pasteur-00819966⟩

Share

Metrics

Record views

77